Clinical trials of mesenchymal stem cells achieve anti-aging process

Two preliminary human clinical anti-aging tests have been shown to be successful. Stem cell therapy shows a reversal of age-related, weakness-related systems. The results show that this treatment is not only safe, but it is also very effective against the key factors of aging. Scientists have been studying various methods to achieve anti-aging goals. Recent discoveries include restoring hair and improving bodybuilding protein. This particular trial involves anti-aging stem cell therapy.


Mesenchymal stem cells (MSCs) are used to treat dozens of different types of pathological conditions such as cancer and heart disease. This new MSC treatment aims to reduce the effects of frailty in the elderly.
This treatment involves the extraction of human mesenchymal stem cells from adult donor bone marrow and a single infusion of patients with an average age of 76 years. Phases 1 and 2 of the preliminary human clinical trial showed no adverse effects on the patient's health.
The first trial involved 15 donors aged between 20 and 45 years. All patients showed improved overall quality of life, indication indications, and tumor necrosis factor levels after 6 months.
In the second trial, no adverse reactions were reported, and the researchers pointed out that the physical improvement of those who received the infusion was "significant."

Industrial Belt

Jiangsu Bailite Transmission Technology Co., Ltd , https://www.bailitebelt.com